BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)
Topic

PfizerBioNTech

EU regulator backs Pfizer-BioNTech COVID-19 vaccine for adolescents

EU regulator backs Pfizer-BioNTech COVID-19 vaccine for adolescents

Published 28 May, 2021 08:23pm
  • The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech, to include 12- to 15-year-olds. It is already being used in the European Union for those aged 16 and older.
  • Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the pandemic.
EU seeks new contract with Pfizer for up to 1.8bn vaccines from 2022

EU seeks new contract with Pfizer for up to 1.8bn vaccines from 2022

Published 09 Apr, 2021 08:43pm
  • Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.
  • Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.
Pfizer/BioNTech say data suggests vaccine 94pc effective in preventing asymptomatic infection

Pfizer/BioNTech say data suggests vaccine 94pc effective in preventing asymptomatic infection

Updated 11 Mar, 2021 10:04pm
  • There were only a limited number of infections in Israel caused by the so-called South African variant - known as B.1.351 - so they were not able to evaluate effectiveness against this variant.
  • In terms of population covered, Israel is leading the world in its vaccination programme, thanks in part to an agreement to share data with Pfizer and BioNTech.
Sixteen African nations show interest in AU vaccine plan

Sixteen African nations show interest in AU vaccine plan

Published 04 Feb, 2021 09:25pm
  • Africa CDC Director John Nkengasong said the 16 countries had asked for a total of a total 114 million doses under the AU's Vaccine Acquisition Task Team (AVATT).
  • "Our hope is that in the next two to three weeks, they should be having their vaccines," he told a virtual news conference.
Pakistan to receive 17.2 million COVID-19 doses through COVAX

Pakistan to receive 17.2 million COVID-19 doses through COVAX

Published 04 Feb, 2021 11:44am
  • The distribution list includes doses of the AstraZeneca-Oxford vaccine, licensed to the Serum Institute of India, Pfizer-BioNTech vaccine and AstraZeneca-Oxford vaccine.
  • The distribution aims to cover an average of 3.3% of total population of 145 countries by mid-2021.
Loading...